The largest-ever gathering in the Australian life sciences!

International BioFest 2016 will be the largest-ever gathering in Australian life sciences, with three major conferences coming together in one week in one place as one integrated network. The event will be held from 24-27 October 2016 in Melbourne by AusBiotech.

Conferences include the 17th International Biotechnology Symposium (IBS 2016), presenting the most advanced topics in biotechnology, green chemistry and its related fields; AusBiotech 2016, Australia’s national life science conference; and Australia Biotech Invest, Australia’s life science investment showcase.

Delegates from the biotechnology, biopharmaceutical, life sciences, business, investment, research, academic and health sectors will gather to celebrate Australian and international life sciences and highlight Melbourne as one of the world’s great biotechnology hubs.

 

Register now                                                                               Find out more

 

FreeMind Group to discuss alternative funding

Ayal Ronen, Vice President, FreeMind Group, will be part of the panel discussing alternative funding, discussing how this flexible funding model can be used within the life science sector. Mr Ronen will be joined by Bill Best, Managing Director, On Market Book Builds, and Ross Curtin, CEO, WealthSpring International Group.

View the program

Ayal Ronen, FreeMind’s Vice President, will be visiting the Research Triangle Park in North Carolina in late July and will be presenting at the NC Biotechnology Center‘s Hamner Conference Center on July 22.

Ayal will provide insight into the non-dilutive funding landscape with an emphasis on the NIH, DOD, and BARDA and will describe the various mechanisms and pockets of money available, potential for funding, and means to maximize chances for award.

There will also be an opportunity to meet with Ayal following the presentation where you can speak more directly about your specific organization and its funding needs. To schedule a 1×1, please email Irina.

This presentation is free and open to all, but registration is required.

Register here

View Agenda

Join Director of Business Development, Meytal Waiss, for a Lunch n Learn presentation on June 27th at the PA Biotechnology Center in Doylestown, PA, supported by the Baruch S. Blumberg Institute.

Come hear Meytal provide insight into the non-dilutive funding landscape with an emphasis on the NIH, DOD, and BARDA, as she describes the various mechanisms and pockets of money available, potential for funding, means to maximize chances for award, and a special funding assistance for Pennsylvania organizations applying for SBIR/STTR grants.

Lunch will be provided and attendance is free, but registration is required.

Register here

Lunch n Learn Agenda

[vc_row][vc_column][vc_column_text]

Ram May-Ron and Ayal Ronen of the FreeMind Group introduce the R&DMoneyView, a tool that will allow its users to gain insight into non-dilutive Federal awards made to domestic, for-profit organizations to support R&D in the Life Sciences.

R&DMoneyView is the first tool in the R&DMoney suite of tools designed to streamline the granting process in a cost-efficient manner while maximizing chances for award.

[/vc_column_text][/vc_column][/vc_row]

Representatives from federal agencies, a private foundation, and industry come together to provide insight into key industry-related initiatives from the various sources as well as the overall enthusiasm for awarding for-profit organizations.

Moderator: Ayal Ronen, FreeMind Group
Panelists:
Dr. Michael Kurilla, NIAID
Todd Merchak, NIBIB,
Dr. Mark Allegretta, National MS Society
Colonel Russell Coleman, DOD (JPM-MCS)
Dr. Natalie Wisniewski, Profusa, Inc.

Colonel Russell E. Coleman of the JPM-Medical Countermeasure Systems, presents the Keynote Address: The Dilemma in the Development of Medical Countermeasures Against Chemical and Biological Weapons: An unpredictable threat and products we hope will never be used.

Dr. Michael Kurilla of the National Institute of Allergy and Infectious Diseases takes a look at the progression of Infectious Diseases, where vaccine and treatment trends may be heading, and NIAID’s role in addressing unmet needs.